Table 2 Main characteristics of each risk factor
From: Risk factors of embolism for the cardiac myxoma patients: a systematic review and metanalysis
Risk Factors | No. Studies | Effect Model | I2, % | Ph | MD/OR | Effect Size (95% CI) | P |
|---|---|---|---|---|---|---|---|
sex(male) | 12 | F | 16.8 | 0.28 | OR | 1.21(0.96–1.53) | 0.11 |
age | 9 | R | 76.8 | < 0.01 | MD | -0.04(−3.64–3.56) | 0.94 |
BMI | 4 | R | 83.7 | < 0.01 | MD | 1.21(−0.43–2.84) | 0.18 |
NYHA class(I/II) | 4 | F | 0.0 | 0.61 | OR | 2.98(1.66–5.33) | < 0.01* |
smoking | 6 | F | 0.0 | 0.44 | OR | 0.90(0.64–1.28) | 0.56 |
LVEF | 6 | F | 7.0 | 0.37 | MD | 0.59(−0.20–1.38) | 0.14 |
hypertension | 8 | F | 0.1 | 0.43 | OR | 1.41(1.04–1.92) | 0.03* |
diabetes | 8 | F | 0.0 | 0.73 | OR | 1.32(0.89–1.94) | 0.16 |
hyperlipidemia | 6 | F | 0.0 | 0.79 | OR | 0.99(0.53–1.85) | 0.96 |
atrial fibrillation | 7 | F | 48.5 | 0.07 | OR | 1.25(0.88–1.80) | 0.22 |
valvular heart disease | 3 | F | 0.0 | 0.62 | OR | 0.76(0.41–1.40) | 0.38 |
coronary heart disease | 3 | R | 84.2 | < 0.01 | OR | 0.99(−0.87–2.85) | 0.32 |
tumor surface(irregular) | 11 | F | 40.4 | 0.08 | OR | 3.99(3.04–5.25) | < 0.01* |
tumor size | 8 | R | 83.3 | < 0.01 | MD | -0.10(−0.76–0.57) | 0.78 |
tumor location(atypical) | 4 | F | 15.9 | 0.31 | OR | 1.81(1.13–2.88) | 0.01* |
tumor base size | 2 | F | 0.0 | 0.66 | MD | −0.36(−0.51--0.22) | < 0.01* |
PLT | 3 | F | 0.0 | 0.83 | MD | 9.95(−6.02–25.91) | 0.22 |
WBC | 4 | F | 34.6 | 0.21 | MD | 0.18(−0.33–0.68) | 0.49 |
HB | 4 | F | 0.0 | 0.40 | MD | 1.65(−2.91–6.21) | 0.48 |
FIB | 2 | F | 0.0 | 0.57 | MD | 0.62(0.28–0.95) | < 0.01* |